A Phase 2 Study of EMD 121974 [cilengitide] as Maintenance Therapy for Patients With Acute Myeloid Leukemia in Complete Remission
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2015
At a glance
- Drugs Cilengitide (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 01 Jun 2006 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 25 Sep 2005 New trial record.